Treatment of heart failure with reduced ejection fraction, the clinical correlate of the animal models used to investigate heart failure, is largely based on medications that reduce the detrimental activation of the renin–angiotensin–aldosterone and sympathetic nervous system [29]. The gene discussed is REN; the disease is heart failure.